New York, December 01, 2014 -- Moody's Investors Service assigned a provisional (P)A3 rating to the proposed note offering of Medtronic, Inc. and expects the rating outlook to be negative. The proceeds of this offering will largely be used to fund a portion of the acquisition of Covidien plc. Medtronic anticipates the acquisition to close in early 2015.

Vollständigen Artikel bei Moodys lesen